Neuronetics, Inc. (STIM) stock
STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.25+0.01 (+0.81%)
Close on Nov 20, 2026Market cap $95.25MP/E –Yield –
Neuronetics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Neuronetics's gross profit for the twelve months ending Jun 30, 2026 was $76.19M, up 22.1% year over year. For fiscal 2025 it was $72.31M, up 33.5% from the year before. The highest annual figure on record is $72.31M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $72.31M | +33.5% |
| FY2024 | Dec 31, 2024 | $54.16M | +4.8% |
| FY2023 | Dec 31, 2023 | $51.71M | +4.0% |
| FY2022 | Dec 31, 2022 | $49.72M | +13.9% |
| FY2021 | Dec 31, 2021 | $43.66M | +15.8% |
| FY2020 | Dec 31, 2020 | $37.69M | -20.3% |
| FY2019 | Dec 31, 2019 | $47.27M | +17.2% |
| FY2018 | Dec 31, 2018 | $40.33M | +30.9% |
| FY2017 | Dec 31, 2017 | $30.80M | +11.6% |
| FY2016 | Dec 31, 2016 | $27.61M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $21.22M | +19.5% |
| Q1 FY2026 | Mar 31, 2026 | $16.15M | +2.6% |
| Q4 FY2025 | Dec 31, 2025 | $21.70M | +45.7% |
| Q3 FY2025 | Sep 30, 2025 | $17.11M | +22.2% |
| Q2 FY2025 | Jun 30, 2025 | $17.76M | +45.8% |
| Q1 FY2025 | Mar 31, 2025 | $15.74M | +20.2% |
| Q4 FY2024 | Dec 31, 2024 | $14.89M | -5.6% |
| Q3 FY2024 | Sep 30, 2024 | $14.00M | +19.0% |
| Q2 FY2024 | Jun 30, 2024 | $12.18M | -4.7% |
| Q1 FY2024 | Mar 31, 2024 | $13.09M | +14.8% |
| Q4 FY2023 | Dec 31, 2023 | $15.77M | +14.2% |
| Q3 FY2023 | Sep 30, 2023 | $11.76M | -9.0% |
| Q2 FY2023 | Jun 30, 2023 | $12.77M | +3.9% |
| Q1 FY2023 | Mar 31, 2023 | $11.40M | +6.5% |
| Q4 FY2022 | Dec 31, 2022 | $13.81M | +20.2% |
| Q3 FY2022 | Sep 30, 2022 | $12.93M | +21.3% |
| Q2 FY2022 | Jun 30, 2022 | $12.29M | +7.3% |
| Q1 FY2022 | Mar 31, 2022 | $10.70M | +6.2% |
| Q4 FY2021 | Dec 31, 2021 | $11.48M | -2.8% |
| Q3 FY2021 | Sep 30, 2021 | $10.66M | +8.8% |
| Q2 FY2021 | Jun 30, 2021 | $11.45M | +54.4% |
| Q1 FY2021 | Mar 31, 2021 | $10.07M | +16.2% |
| Q4 FY2020 | Dec 31, 2020 | $11.82M | -10.1% |
| Q3 FY2020 | Sep 30, 2020 | $9.79M | -17.1% |
| Q2 FY2020 | Jun 30, 2020 | $7.42M | -40.2% |
| Q1 FY2020 | Mar 31, 2020 | $8.67M | -12.7% |
| Q4 FY2019 | Dec 31, 2019 | $13.14M | +10.2% |
| Q3 FY2019 | Sep 30, 2019 | $11.81M | +10.3% |
| Q2 FY2019 | Jun 30, 2019 | $12.40M | +23.9% |
| Q1 FY2019 | Mar 31, 2019 | $9.92M | +28.9% |
| Q4 FY2018 | Dec 31, 2018 | $11.92M | +30.3% |
| Q3 FY2018 | Sep 30, 2018 | $10.70M | +36.3% |
| Q2 FY2018 | Jun 30, 2018 | $10.01M | +28.2% |
| Q1 FY2018 | Mar 31, 2018 | $7.70M | +28.5% |
| Q4 FY2017 | Dec 31, 2017 | $9.15M | – |
| Q3 FY2017 | Sep 30, 2017 | $7.86M | – |
| Q2 FY2017 | Jun 30, 2017 | $7.81M | – |
| Q1 FY2017 | Mar 31, 2017 | $5.99M | – |
See a number that looks wrong?